Skip to content

5 – 9 avril 2014

  • by

Alethia Biothérapeutiques participera à la conférence annuelle de l’ACCR au centre des congrès de San Diego.  Les Dr Mario Filion et Gilles Tremblay présenteront des résultats portant sur:

AB-3A4: A novel KAAG1-targeting antibody-drug conjugate is active in models of ovarian carcinoma, triple-negative breast cancer and castration-resistant prostate cancer.  6 avril, 2014, 1:00 PM – 5:00 PM; Hall A-E, Poster Section 28

situs togel

link gacor

link gacor

situs togel

bandar togel

situs slot

situs togel

situs toto

toto togel

situs toto

situs togel

slot gacor

link gacor

link gacor

situs toto

situs toto

situs toto

togel online

slot gacor

link gacor

situs toto

togel online

slot gacor

link gacor

kampungbet

situs toto

kampungbet

link gacor

slot gacor

slot gacor

link gacor

toto togel

slot gacor

slot gacor

slot gacor

slot gacor

situs togel

slot gacor

kampungbet

slot gacor

slot gacor

slot gacor

slot gacor

slot gacor

situs toto

kampungbet

kampungbet

kampungbet

slot gacor

slot gacor

link gacor

slot gacor

link gacor

slot gacor

link gacor

situs toto

kampungbet

link gacor

link gacor

link gacor

slot gacor

slot gacor

slot gacor

link gacor

kampungbet

optima kemasan prima

slot gacor

kampungbet

situs gacor

link gacor

jual plastik kemasan

kampungbet

kampungbet

kampungbet

kampungbet

kampungbet

kampungbet

kampungbet

kampungbet

situs toto

kampungbet

kampungbet

kampungbet

slot gacor

situs gacor

slot gacor

link gacor

situs gacor

link gacor

slot gacor

Leave a Reply

Your email address will not be published. Required fields are marked *